Takou, D., Fokam, J., Teto, G., Santoro, M.-., Ceccherini-Silberstein, F., Nanfack, A.J., et al. (2019). HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: Evidence from routine clinical practice in Cameroon. BMC INFECTIOUS DISEASES, 19(1), 246 [10.1186/s12879-019-3871-0]. Dettagli
10.1186/s12879-019-3871-0
CitazioneTakou, D., Fokam, J., Teto, G., Santoro, M.-., Ceccherini-Silberstein, F., Nanfack, A.J., et al. (2019). HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: Evidence from routine clinical practice in Cameroon. BMC INFECTIOUS DISEASES, 19(1), 246 [10.1186/s12879-019-3871-0].Data2019idPUBBLICAZIONE_379708TipologiaArticolo su rivistaSSDSettore MED/07Tutti gli AutoriHIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: Evidence from routine clinical practice in CameroontipologiaTakou, D; Fokam, J; Teto, G; Santoro, M-; Ceccherini-Silberstein, F; Nanfack, AJ; Sosso, SM; Dambaya, B; Salpini, R; Billong, SC; Gori, C; Fokunang, CN; Cappelli, G; Colizzi, V; Perno, C-; Ndjolo, A